Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-09-06Clinical Trial Update: Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update evaluating postoperative proton radiotherapy with chemotherapy for pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-09-01Clinical Trial Update: Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating gemcitabine, cisplatin, epirubicin, and capecitabine in stage I–II resectable pancreatic cancer has comple…
-
CLINICAL_TRIALS trial_result · 2017-09-01Clinical Trial Update: A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma [Phase 1, Phase 2]
A Phase I/II trial evaluating the investigational agent PAXG in patients with stage III–IV pancreatic adenocarcinoma has completed.
-
CLINICAL_TRIALS research · 2017-09-01Clinical Trial Update: The Effect of Application of TachoSil® in Pancreatoduodenectomy [Phase 4]
Phase 4 clinical trial update evaluating the use of the surgical patch TachoSil in pancreatoduodenectomy for pancreatic conditions; current …
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer [Phase 2]
Phase 2 study of a modified FOLFIRINOX regimen in advanced pancreatic cancer has completed enrollment with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer. [EARLY_Phase 1]
An early-phase (Phase 1) study is evaluating the safety and efficacy of CAR-T cell therapy in pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Study of Neoadjuvant Treatment in Patients With Pancreatic Cancer That is Potentially Resectable [Phase 2]
A Phase 2 neoadjuvant trial for potentially resectable pancreatic cancer has been terminated.
-
CLINICAL_TRIALS research · 2017-08-29Clinical Trial Update: Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas [NA]
Clinical evaluation of needle-based confocal laser endomicroscopy for lymph nodes and pancreatic lesions is being updated; no results or sta…
-
CLINICAL_TRIALS research · 2017-08-29Clinical Trial Update: A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial is evaluating administering the FOLFIRINOX chemotherapy regimen before surgery for potentially curable pancreatic c…
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract
Clinical trial registry update indicating completion of NCT01770405 evaluating needle-based confocal laser endomicroscopy (nCLE) for masses …
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating S-1 in combination with gemcitabine and erlotinib for advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery [Phase 1]
A Phase 1 study evaluating the combination of dinaciclib and MK-2206 in patients with unresectable pancreatic cancer (pancreatic adenocarcin…
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer [Phase 2]
Phase 2 trial of the FOLFIRINOX regimen in unresectable locally advanced and borderline resectable pancreatic cancer was terminated, with re…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: 3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 1]
Phase 1 trial evaluating the combination of 3-AP (Triapine) with radiation therapy in patients with unresectable stage III pancreatic cancer…
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma [Phase 1]
Phase 1 study evaluating the safety and preliminary efficacy of PRI-724 in combination with gemcitabine in patients with advanced or metasta…
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma [Phase 1]
This document reports the completion of a Phase 1 trial evaluating the combination of FOLFIRINOX with IPI-926 in adults with advanced pancre…
-
CLINICAL_TRIALS trial_result · 2017-08-04Clinical Trial Update: QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer [Phase 1, Phase 2]
Clinical trial update for QUILT-3.019 indicates the Phase 1/2 study of NPC-1C monoclonal antibody for metastatic pancreatic and metastatic c…
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Evaluating the Number of Passes Required for Diagnostic Cell Block During EUS-FNA of Solid Pancreatic Mass Lesions [NA]
A completed clinical trial evaluating the number of passes required for diagnostic cell block during EUS-FNA of solid pancreatic mass lesion…
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Trial Comparing 19 and 25G Needles for Fine Needle Aspiration (FNA) of Solid Pancreatic Mass Lesions Greater Than 35mm [NA]
Clinical trial comparing 19- and 25-gauge needles for fine-needle aspiration of solid pancreatic masses larger than 35 mm. The study status …
-
FDA approval · 2017-08-03FDA Approved: GEMCITABINE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's gemcitabine injectable drug as an original application, providing a generic version of the anticancer agent…
-
CLINICAL_TRIALS research · 2017-08-02Clinical Trial Update: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating nonmyeloablative allogeneic hematopoietic stem cell transplantation as a treatment for pancreatic cancer…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer [Phase 2]
This Phase 2 trial in metastatic pancreatic cancer compared gemcitabine-erlotinib with gemcitabine-erlotinib-capecitabine to evaluate safety…
-
CLINICAL_TRIALS research · 2017-08-01Clinical Trial Update: Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) [NA]
A completed clinical trial update describing the characterization of circulating tumor cells captured via c-MET (CTC-MET) across multiple ca…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer [Phase 1]
Phase 1 clinical trial update for a vaccine therapy in patients with colorectal, gastric, pancreatic, or rectal cancer has completed enrollm…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Concurrent Hyperthermia and Chemoradiotherapy in LAPC: Phase II Study [Phase 2]
Phase II study evaluating concurrent hyperthermia with chemoradiotherapy for locally advanced pancreatic cancer is being conducted at Kanton…